Astellas Pharma US
Pharmaceutical company
Based in IL
🤖
AI Overview
With $1.3M in lobbying spend across 34 quarterly filings, Astellas Pharma US is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$1.3M
Total Spend
8
Years Active
1
Firms Hired
10
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $160K |
| 2019 | $160K |
| 2020 | $160K |
| 2021 | $160K |
| 2022 | $160K |
| 2023 | $160K |
| 2024 | $200K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Defense, Law Enforcement
- •Issues related to pharmaceuticals and health care.
- •National Defense Authorization Act for Fiscal Year 2019
- •Issues related to pharmaceutical pricing and NIH March In Rights
- •Issues related to pharmaceutical pricing
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.